5 year follow-up results of the HERAKLES study: superior renal function after early conversion to an everolimus-based calcineurin inhibitor free regimen.

被引：0
|
作者：
Sommerer, Claudia [1 ]
Budde, Klemens [1 ]
Arns, Wolfgang [1 ]
Reinke, Petra [1 ]
Guba, Markus [1 ]
Weithofer, Peter [1 ]
Vogt, Bruno [3 ]
Jacobi, Johannes [1 ]
Stahl, Rolf [1 ]
Rath, Thomas [1 ]
Hauser, Ingeborg A. [1 ]
Porstner, Martina [2 ]
May, Christoph [2 ]
Lehner, Frank [1 ]
Witzke, Oliver [1 ]
机构：
[1] Herakles, Study Grp, Berlin, Germany
[2] Novartis, Pharma, Wehr, Germany
[3] Herakles, Study Grp, Basel, Switzerland
来源：
TRANSPLANTATION | 2016年 / 100卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P.1528
引用
收藏
页码：S724 / S724
页数：1
相关论文
共 50 条
  • [31] Renal Function Outcomes in Kidney Transplant Recipients After Conversion to Everolimus-Based Immunosuppression Regimen with CNI Reduction or Elimination
    Cataneo-Davila, A.
    Zuniga-Varga, J.
    Correa-Rotter, R.
    Alberu, J.
    [J]. TRANSPLANTATION PROCEEDINGS, 2009, 41 (10) : 4138 - 4146
  • [32] Efficacy and safety of three different treatment regimen in de novo renal transplant patients: 5 year follow-up results of the HERAKLES trial
    Budde, Klemens
    Sommerer, Claudia
    Arns, Wolfgang
    Kliem, Volker
    Vogt, Bruno
    Guba, Markus
    Jacobi, Johannes
    Hauser, Ingeborg A.
    Stahl, Rolf
    Reinke, Petra
    Rath, Thomas
    May, Christoph
    Porstner, Martina
    Witzke, Oliver
    Lehner, Frank
    [J]. TRANSPLANTATION, 2016, 100 (07) : S725 - S725
  • [33] Renal function three years after early conversion from a calcineurin inhibitor to everolimus: results from a randomized trial in kidney transplantation
    Mjornstedt, Lars
    Sorensen, Soren Schwartz
    von zur Muhlen, Bengt
    Jespersen, Bente
    Hansen, Jesper M.
    Bistrup, Claus
    Andersson, Helene
    Gustafsson, Bengt
    Solbu, Dag
    Holdaas, Hallvard
    [J]. TRANSPLANT INTERNATIONAL, 2015, 28 (01) : 42 - 51
  • [34] Improved Renal Function After Early Conversion From a Calcineurin Inhibitor to Everolimus: a Randomized Trial in Kidney Transplantation
    Mjornstedt, L.
    Sorensen, S. S.
    von zur Muhlen, B.
    Jespersen, B.
    Hansen, J. M.
    Bistrup, C.
    Andersson, H.
    Gustafsson, B.
    Undset, L. H.
    Fagertun, H.
    Solbu, D.
    Holdaas, H.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (10) : 2744 - 2753
  • [35] First Results of Early Conversion to Everolimus in Patients after Lung Transplantation: A 9-Month Follow-Up of Renal Function and Spirometry Data
    Baum, C.
    Deuse, T.
    Oldigs, M.
    Sill, B.
    Oelschner, C.
    Costard-Jaeckle, A.
    Reichenspurner, H.
    [J]. TRANSPLANTATION, 2012, 94 (10) : 192 - 192
  • [36] Long-Term Results in Recipients of Late Conversion to a Calcineurin Inhibitor-Free Regimen with Everolimus After Kidney Transplantation
    Iwahara, Naoya
    Hotta, Kiyohiko
    Hirose, Takayuki
    Shinohara, Nobuo
    [J]. TRANSPLANTATION PROCEEDINGS, 2023, 55 (04) : 803 - 808
  • [37] EFFICACY AND SAFETY OF THREE DIFFERENT TREATMENT REGIMEN IN DE NOVO RENAL TRANSPLANT PATIENTS: 5-YEAR FOLLOW-UP RESULTS OF THE HERAKLES TRIAL
    Guba, M.
    Lehner, F.
    Budde, K.
    Arns, W.
    Hauser, I.
    Rath, T.
    Jacobi, J.
    Reinke, P.
    Stahl, R.
    Vogt, B.
    Junge, M.
    Kliem, V.
    Sommerer, C.
    Witzke, O.
    [J]. TRANSPLANT INTERNATIONAL, 2016, 29 : 27 - 27
  • [38] Everolimus after heart transplantation: 4 years' single center follow-up in calcineurin inhibitor-free immunosuppression
    Engelen, M. A.
    Gunia, S.
    Klarner, P.
    Schlarb, D.
    Amler, S.
    Sindermann, J. R.
    Stypmann, J.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 : 207 - 208
  • [39] Improved Renal Function of an Everolimus/Enteric-Coated Mycophenolate Sodium Regimen after Calcineurin Inhibitor Withdrawal in De Novo Renal Transplant Patients: 3 Years Follow-Up of the ZEUS Trial
    Budde, K.
    Arns, W.
    Sommerer, C.
    Reinke, P.
    Eisenberger, U.
    Vogel, E. -M.
    Kramer, S.
    Witzke, O.
    Becker, T.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 66 - 66
  • [40] Improved Renal Function of an Everolimus/Enteric-Coated Mycophenolate Sodium Regimen after Calcineurin Inhibitor Withdrawal in De Novo Renal Transplant Patients: 2 Years Follow-Up of the ZEUS Trial
    Budde, K.
    Arns, W.
    Sommerer, C.
    Reinke, P.
    Eisenberger, U.
    Fischer, W.
    Kramer, S.
    Pietruck, F.
    Becker, T.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 503 - 503
12345